Review
YANG Yan, CHEN Xiaohua, DAI Yucheng, ZHOU Liwei, CAI Weiming, GUO Liangdong, CUI Baokai, LI Ning, LEI Ping, LI Changtian, LI Zhengpeng, SHI Wei, LU Benkun, QIN Shaoxin, WANG Rongxiang, LI Xifan, SONG Jindi, YAO Shengliang, ZHANG Anqiang, JIANG Ning, WAN Heyan, DING Faliang, ZHANG Henan, ZHENG Zhonggui, ZHANG Shengming, ZHOU Hongying, FAN Yuguang, CHEN Wanchao, YU Xinhui, TANG Shichao, ZHANG Yanfei, ZHANG Qinxue, WANG Kun, YAN Jingkun, LIU Di, WANG Chenguang, YANG Baoyu, CHEN Weichun, LI Tingting, MO Yan, FU Junsheng, WU Deping, SONG Bin, LIU Jie, WANG Jun, ZHOU Wei, GENG Junju, ZHAO Jing, LI Qing’en
Sanghuang, as a group of medicinal macrofungi recorded in ancient Chinese traditional medicine books, has many functions such as anti-tumor, reduction of blood suger, reduction of blood fat, anti-oxidation, and reduction of uric acid. Modern taxonomic studies have shown that sanghuang has high species diversity and widely distributed in different areas of China and other areas of north Hemisphere, growing in mulberry, poplar, clove, honeysuckle, northeast China ash, jujube, walnut and other broad-leaved trees. Sanghuang have been artificially cultivated in China since 1990s, and the species used for cultivation are mainly Sanghuangporus sanghuang, S. vaninii, S. baumii, and Inonotus hispidus. The scale of the sanghuang industry is progressively expanding, forming a health industry with high economic value and social benefits. In this paper, we summarized the current status of sanghuang industry in China, relating to the historical record, the change of classification status, the functional researches, production development, bottleneck problems and countermeasures. The problems existing in sanghuang industry development, and some recommendations for its future development in China are proposed.